These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30091043)

  • 21. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
    Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges of Vaccine Development for Zika Virus.
    Blackman MA; Kim IJ; Lin JS; Thomas SJ
    Viral Immunol; 2018 Mar; 31(2):117-123. PubMed ID: 29227202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.
    Vázquez-Ramírez D; Jordan I; Sandig V; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2019 Apr; 103(7):3025-3035. PubMed ID: 30796494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zika, dengue and yellow fever viruses induce differential anti-viral immune responses in human monocytic and first trimester trophoblast cells.
    Luo H; Winkelmann ER; Fernandez-Salas I; Li L; Mayer SV; Danis-Lozano R; Sanchez-Casas RM; Vasilakis N; Tesh R; Barrett AD; Weaver SC; Wang T
    Antiviral Res; 2018 Mar; 151():55-62. PubMed ID: 29331320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation.
    White KM; Ayllon J; Mena I; Potenski A; Krammer F; García-Sastre A
    Vaccine; 2018 Feb; 36(9):1146-1153. PubMed ID: 29395518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture.
    Liu CC; Wu SC; Wu SR; Lin HY; Guo MS; Yung-Chih Hu A; Chow YH; Chiang JR; Shieh DB; Chong P
    Vaccine; 2018 May; 36(22):3134-3139. PubMed ID: 28274636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
    Gränicher G; Coronel J; Pralow A; Marichal-Gallardo P; Wolff M; Rapp E; Karlas A; Sandig V; Genzel Y; Reichl U
    Vaccine; 2019 Nov; 37(47):7019-7028. PubMed ID: 31005427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T Cell Immunity and Zika Virus Vaccine Development.
    Lima NS; Rolland M; Modjarrad K; Trautmann L
    Trends Immunol; 2017 Aug; 38(8):594-605. PubMed ID: 28579320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor.
    Berrie DM; Waters RC; Montoya C; Chatel A; Vela EM
    Vaccine; 2020 Apr; 38(20):3639-3645. PubMed ID: 32247568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease.
    Barrett ADT
    Vaccine; 2017 Oct; 35(44):5951-5955. PubMed ID: 28366605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying Attenuating Mutations: Tools for a New Vaccine Design against Flaviviruses.
    Khou C; Pardigon N
    Intervirology; 2017; 60(1-2):8-18. PubMed ID: 28869941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.
    Slon Campos JL; Poggianella M; Marchese S; Mossenta M; Rana J; Arnoldi F; Bestagno M; Burrone OR
    PLoS One; 2017; 12(7):e0181734. PubMed ID: 28742857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture.
    Petiot E; Jacob D; Lanthier S; Lohr V; Ansorge S; Kamen AA
    BMC Biotechnol; 2011 Sep; 11():84. PubMed ID: 21884612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of yellow fever virus produced in Vero cells for inactivated vaccine manufacture.
    Pato TP; Souza MCO; Mattos DA; Caride E; Ferreira DF; Gaspar LP; Freire MS; Castilho LR
    Vaccine; 2019 May; 37(24):3214-3220. PubMed ID: 31047674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The early cellular signatures of protective immunity induced by live viral vaccination.
    Kohler S; Bethke N; Böthe M; Sommerick S; Frentsch M; Romagnani C; Niedrig M; Thiel A
    Eur J Immunol; 2012 Sep; 42(9):2363-73. PubMed ID: 22733156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioreactor concepts for cell culture-based viral vaccine production.
    Gallo-Ramírez LE; Nikolay A; Genzel Y; Reichl U
    Expert Rev Vaccines; 2015; 14(9):1181-95. PubMed ID: 26178380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.